Clinical study on the effect of Anning therapeutics combined with Bufei Decoction on the quality of life of patients with end-stage non-small cell lung cancer (NSCLC) (Qi deficiency syndrome)

Not Applicable

Recruiting

• Conditions: End stage non-small cell lung cancer

• Registration Number: ITMCTR2200006449
• Lead Sponsor: Beijing Gulou Hospital of traditional Chinese Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

? The diagnosis of advanced non-small cell lung cancer (stage ? b- ?) is supported by cellular and pathological diagnosis.
? Those who meet the above diagnostic criteria of Chinese and Western medicine are patients with Qi deficiency syndrome.
? On the premise that the patient fully understands the condition, the estimated survival time can reach 3 months or more.
? The patient knows all the contents of hospice care, and the patient is too weak to receive anti-cancer treatment, or the patient refuses to continue anti-cancer treatment;
? No mental illness and consciousness disorder, can communicate normally;
? On the premise of full knowledge, the patients voluntarily participated in the study, agreed to follow-up and were qualified.
? No treatment with traditional Chinese medicine within 3 months before treatment.

Exclusion Criteria

? Lung cancer was diagnosed as non primary, and the pathological findings did not belong to non-small cell lung cancer. There were other malignant tumors except primary non-small cell lung cancer.
? There are serious primary diseases such as cardiovascular and cerebrovascular diseases, or other serious diseases such as liver and kidney dysfunction.
? A woman who is breast-feeding or pregnant.
? Patients with disabilities specified by law, including blindness, deafness, muteness, intellectual or mental disorders, and physical disabilities.
? Have a definite history of food and drug allergy, have a clear experience of allergy to the ingredients contained in the drugs used in the experiment, and have an allergic constitution.
? For the purpose of ensuring the smooth progress of the experiment, the patients who are considered by the researcher to be unsuitable for enrollment or whose possibility of enrollment is too low.
? Patients who have not finished or are difficult to exclude the impact of other clinical studies

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
EORTC QLQ-C30;ECOG;CFS;